Core Insights - Waters Corporation (WAT) is a leading company in analytical instruments and scientific software, with a market cap of $23.6 billion, serving various industries including pharmaceuticals and life sciences [1][2] Company Performance - WAT is classified as a large-cap stock, reflecting its significant size and influence in the diagnostics and research industry [2] - The company's stock is currently trading 6.5% below its 52-week high of $423.56, but has increased by 35.1% over the past three months, outperforming the Nasdaq Composite's 8.1% rise [3] - Over the past 52 weeks, WAT's stock has gained 1.4%, which is below the Nasdaq's 20.2% increase, and on a year-to-date basis, WAT is up 6.7% compared to Nasdaq's 22.5% return [4] Recent Financial Results - On November 4, WAT's shares surged 6.3% following strong Q3 results that exceeded analyst expectations [5] - The company's net sales for Q3 improved by 8% year-over-year to $800 million, surpassing consensus estimates by 2.6% [5] - Adjusted EPS climbed 16% from the previous year to $3.40, exceeding analyst expectations of $3.21, and WAT raised its fiscal 2025 sales and adjusted EPS guidance [5]